HOXB7 and breast carcinoma: HOXB7 confers epithelial-mesenchymal transition in breast cancer62, promotes malignant progression by activation of TGF signalling63 and lung metastasis64 and renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway65.